ANIX Projected Dividend Yield

Anixa Biosciences Inc ( NASDAQ : ANIX )

Anixa Biosciences is a biotechnology company. Co.'s vaccine programs include: the development of a preventative vaccine against triple negative breast cancer and other forms of breast cancer; and the development of a preventative vaccine against ovarian cancer. Co.'s therapeutics programs include: the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer, which is being developed at its subsidiary, Certainty Therapeutics, Inc.; and the development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus.

20 YEAR PERFORMANCE RESULTS